THE EXPANDING CLINICAL PHENOTYPE OF THE TRNA(LEU(UUR)) A-]G MUTATION AT NP-3243 OF MITOCHONDRIAL-DNA - DIABETIC EMBRYOPATHY ASSOCIATED WITHMITOCHONDRIAL CYTOPATHY
A. Feigenbaum et al., THE EXPANDING CLINICAL PHENOTYPE OF THE TRNA(LEU(UUR)) A-]G MUTATION AT NP-3243 OF MITOCHONDRIAL-DNA - DIABETIC EMBRYOPATHY ASSOCIATED WITHMITOCHONDRIAL CYTOPATHY, American journal of medical genetics, 62(4), 1996, pp. 404-409
We describe a family which demonstrates and expands the extreme clinic
al variabilty now known to be associated with the A-->G transition at
nucleotide position 3243 of the mitochondrial DNA. The propositus pres
ented at birth with clinical manifestations consistent with diabetic e
mbryopathy including anal atresia, caudal dysgenesis, and multicystic
dysplastic kidneys. His co-twin was normal at birth, but at 3 months o
f life, presented with intractable seizures later associated with deve
lopmental delay. The twins' mother developed diabetes mellitus type I
at the age of 20 years and gastrointestinal problems at 22 years. Sinc
e age 19 years, the maternal aunt has had recurrent strokes, seizures,
mental deterioration and deafness, later diagnosed as MELAS syndrome
due to the tRNA(Leu(UUR)) A-->G mutation. A maternal uncle had diabete
s mellitus type I, deafness, and normal intellect, and died at 35 year
s after recurrent strokes. This pedigree expands the known clinical ph
enotype associated with tRNA(Leu(UUR)) A-->G mutation and raises the p
ossibility that, in some cases, diabetic embryopathy may be due to a m
itochondrial cytopathy that affects both the mother's pancreas (and re
sults in diabetes mellitus and the metabolic dysfunction associated wi
th it) and the embryonic/fetal and placental tissues which make the em
bryo more vulnerable to this insult. (C) 1996 Wiley-Liss, Inc.